Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -1.905% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CC(C)N(Cc1ccccc1)C(=S)NCc1ccccc1
(b) CCN(CC)C1CCN(Cc2c(C(=O)N3CCCCCCC3)nc3ccc(Cl)cn23)C1
(c) CCn1nnc(NC(=O)c2cc(Cl)c(OC)c(Cl)c2)n1
Answer: b. CCN(CC)C1CCN(Cc2c(C(=O)N3CCCCCCC3)nc3ccc(Cl)cn23)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)C1CCN(Cc2c(C(=O)N3CCCCCCC3)nc3ccc(Cl)cn23)C1
CCN(CC)C1CCN(Cc2c(C(=O)N3CCCCCCC3)nc3ccc(Cl)cn23)C1
azocan-1-yl-[6-chloro-3-[[3-(diethylamino)pyrrolidin-1-yl]methyl]imidazo[1,2-a]pyridin-2-yl]methanone